Wednesday, October 27
12:00 – 1:15 pm
Non-CNE Symposia

Non-CNE Symposium: Nursing Considerations for Asparlas®: A More Stable Pegylated Asparaginase Molecule (SYM7)

Attend this symposium to learn about:

  • Review the clinical efficacy profile of Asparlas®
  • Explore a patient profile to help identify patients who may be appropriate for treatment with Asparlas.
  • Discuss the clinical safety profile, adverse reaction management, and important safety information for Asparlas.


We thank Servier for their generous support of this event.

6:00 – 7:15 pm
Wednesday, October 27
Non-CNE Symposia

Non-CE Satellite Symposia: Case Study: VOD with Renal and Pulmonary Dysfunction Following HSCT in a Pediatric Patient With Neuroblastoma (SYM3)

Join us for a real-world case-based discussion of veno-occlusive disease (VOD) following hematopoietic stem-cell transplantation (HSCT). Topics include identifying factors that put patients at a greater risk for VOD, recognizing the signs and symptoms of VOD, and reviewing recently published diagnostic criteria in order to help make an early and accurate diagnosis of VOD.



We thank Jazz Pharmaceuticals for their generous support of this event.

12:45 pm – 2:00 pm
Saturday, October 30
CNE Presentation

Acute Lymphoblastic Leukemia: Nursing Notes on Asparaginase Hypersensitivity and Silent Inactivation (SYM6 )

Attendees will gain a greater insight into the critical position of the pediatric oncology nurse in monitoring for and managing both ASNase hypersensitivity and the inactivation process which may occur during treatment and be prepared to provide effective education to patients with ALL and their families concerning these issues.

Nursing Credit

MediCom Worldwide, Inc. is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 1.0 contact hour. Program Number: 21-038-148


medicom homepage1

Provided by MediCom Worldwide, Inc. This activity is supported by educational grants from Jazz Pharmaceuticals and Servier Pharmaceuticals LLC.


Katelyn Oranges, MSN CRNP CPHON®

Joseph Sciasci, PharmD, BCOP

CNE Hours
1 Provided by MediCom Worldwid Inc.
4:45 – 6:00 pm
Friday, October 29
Non-CNE Symposia

Discover A Different Treatment for Pediatric Patients with Hemophilia A (SYM4)

Please join us for an engaging symposium led by expert Jennifer Maahs, NP, to learn more about hemophilia A and a subcutaneous treatment option for pediatric patients. She will discuss using a different prophylaxis option, share key clinical data, and answer your questions! This symposium is sponsored by Genentech, Inc.

Genetech homepage

We thank Genetech for their generous support of this event.

10:15 – 11:15 am
Thursday, October 28
Non-CNE Symposia

The Silent Damage of Iron Overload: Best Practices for Optimal Chelation in Transfused Patients With Sickle Cell Disease or Thalassemia (SYM2)

Understanding iron overload and the importance of chelation therapy in transfused patients with sickle cell disease or thalassemia is critical. A nurse expert will review best practices for helping patients achieve optimal chelation and why regular kidney assessment matters and a patient with sickle cell disease will share the real-world experience.© CHIESI USA, Inc. 2021. All rights reserved.
PP-F-0136 V1.0 April 2021

Chiesi homepage

APHON thanks Chiesi for their generous support of this event.

Subscribe to this RSS feed